According to the experts behind the breakthrough BioNTech ‘Pfizer’ Covid-19 shot, a vaccination that attempts to boost the immune system’s reaction to cancer – and even eradicate cancer cells entirely – might be ready by the end of the decade.
Uur ahin and zlem Türeci, a husband and wife team, are the creators of the German vaccine enterprise focusing on the new medical advances, and during the Covid-19 epidemic, the couple collaborated with Pfizer to build the messenger RNA (mRNA) Covid vaccine. More than 3.7 billion Pfizer-BioNTech Covid-19 vaccines had been supplied to 180 countries as of September 4, 2022.
Before the pandemic, ahin and Türeci were already researching cancer immunotherapies and possible vaccinations. During the worldwide emergency, however, the company placed their cancer-related work on hold and focused on creating Covid vaccinations.
During this fast-paced procedure, the medical team learnt how to make mRNA vaccines and got insight into how people’s immune systems reacted to mRNA – the pair claims that their experience with Covid vaccinations over the last several years has aided in the creation of a possible future cancer treatment.
The company is now testing numerous vaccine therapies in clinical trials, including one in which cancer patients are given a personalized vaccination to stimulate their immune system and target their disease.
According to Cancer Research UK, one in every two persons born after 1960 in the United Kingdom will be diagnosed with cancer at some point in their lives.
“Using vaccines to treat individuals with cancer is a fascinating growing subject, and Cancer Research UK is at the forefront of these advancements,” Dr. Mistry says. We are sponsoring cutting-edge research to uncover how virus and vaccine technologies may engage the immune system in the fight against cancer.”
So, while there is still more work to be done before a vaccine is declared safe, effective, and ready for use, we are encouraged to learn that such significant strides are being made in the fight against cancer.
